Today, Alta Partners consists of nine life sciences professionals and one information technology professional, backed by a strong and experienced support team. Collectively, the Alta franchise brings a unique balance of complementary skills to our companies, including venture investing, operational, scientific, clinical, marketing, information technology and investment banking experience.
Our Team
Alta Partners News
- December 05, 2012
BioWorld Today: Alta Partners - Zafgen $21M Raise to Move Beloranib Beyond Phase IIa - January 21, 2011
Medical-Device Investors Lukewarm On Initial FDA Changes - January 13, 2011
Q&A With Alta’s Guy Nohra At J.P. Morgan Healthcare Conference - August 31, 2009
Alta Partners Promotes Robert Alexander, Ph.D. to Director. Adam Tomasi, Ph.D promoted to Principal. - April 30, 2009
Venture Capitalists Honored for Exceptional Service - Jean Deleage Receives NVCA Lifetime Achievement Award - July 23, 2008
Market Conditions Sour IPO Prospects For Some Firms – MDMA Panelists - July 17, 2008
Who'll Stop the Pain? - January 10, 2008
JPMorgan Healthcare Conference - December 17, 2007
Alta Partners Announces $25 Million Investment in Anesiva. - October 01, 2007
Hungry for More - July 05, 2007
Going Generic - April 25, 2007
Health Consumers Become Focus - November 01, 2006
Venture Capital Journal: Alta Partners Fund Profile - October 09, 2006
Alta Partners Promotes Alison de Bord to Director - October 09, 2006
Alta Partners Raises $500M for Eighth Fund - May 05, 2006
Letter to the Editor: 'Gainsharing' Cuts Hospital Costs but Limits Patient Care - March 01, 2006
Venture Capital Journal: Life Sciences Roundtable – Buoyed by Biotech - January 26, 2006
Alta Partners Represented on Forbes "Midas List" - November 07, 2005
Robert Alexander Joins Alta Partners as Principal - September 27, 2005
Seeing Lifesciences Industry Deliver on its Promise - July 19, 2005
Money Flowing in the Fight Against Fat











